Turkey
ALBILA Serum Biological Products Industry and Trade Inc. was founded in 2017 through an Angel Investment initiative. This Turkish company operates with the guiding slogan: "Flexible, Independent & Globally Active." Its significance is underscored by its location within the Eskisehir Industrial Zone as the first and only pharmaceutical production facility based there.
ALBILA specializes in developing equine-based antiserums and antitoxins for animal bites, collaborating with prestigious academic institutions, notably Eskisehir Osmangazi University, among others worldwide. Their facilities boast a 1600 square meter state-of-the-art production and R&D space.
The company's headquarters is situated in Istanbul, while its main production and research facilities are strategically located in Eskisehir, where they also manage a unique scorpion venom production unit and a farm dedicated to horse care and immunization. Despite its advancements, ALBILA has not disclosed its last investment or investors, presenting a potential opportunity for forward-thinking investors keen on the Biotechnology and Life Sciences sectors.
